Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. - Wikidata - wikimedia - TriplyDB

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

http://www.wikidata.org/entity/Q30497419

about

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets The expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohorts Is there clinical value to prognostic signatures in early-stage NSCLC?Yin Yang gene expression ratio signature for lung cancer prognosis Lung Cancer Gene Signatures and Clinical Perspectives Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma One-step extrapolation of the prediction performance of a gene signature derived from a small study Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer Prognostic value of microRNA expression in operable non-small cell lung cancer patients Predicting Prognosis of Early-Stage Non-Small Cell Lung Cancer Using the GeneFx® Lung Signature Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation A simple but highly effective approach to evaluate the prognostic performance of gene expression signatures Integrative computational biology for cancer research Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.Strategies for power calculations in predictive biomarker studies in survival data Integrative Analysis of Gene Networks and Their Application to Lung Adenocarcinoma Studies.Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.Protein signature for non-small cell lung cancer prognosis.Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.Advances in adjuvant systemic therapy for non-small-cell lung cancer.H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes.Relation between smoking history and gene expression profiles in lung adenocarcinomas Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexed.Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy.

P2860

Q27345462-2A861A30-E920-4870-B261-0CF1025D45A3 Q27853293-4FEE69F8-24AB-42E2-9CA6-877370B4CE4A Q28074028-7C11BA0B-747C-4A07-BB61-145A43DC951A Q28383695-7EED563C-EDFE-4BC5-A27C-762A8F883C52 Q28384571-79F69FAA-F19E-4368-8ED1-1EA0FF32B892 Q28385778-4DFDFE2B-D80F-403B-B361-09A10E8EDF47 Q28387769-44153E3B-55B9-4A2F-8A7C-56734EDFF962 Q28388842-8674B5DF-692E-48A8-A1EB-7F7369834569 Q28392088-E50FFA95-4833-4CDD-8D04-5E1F3E9FDDBC Q28393146-826EB5B0-4F9A-4E19-9614-E1A526C05455 Q28394867-42BA1EBD-D240-4668-AE88-02E06A8E6E28 Q28394974-85CFC966-50FD-4EE4-847E-3CAA7D0CC74C Q28396343-8C3F901B-3E00-423A-AD22-C12ADE59288C Q28608174-AA160BB2-8FE6-42D5-A9DD-E97D311CD419 Q28730029-9E26E440-3B1A-4A28-B85A-6EF84C165CD7 Q28741755-8984A595-F58B-485C-9023-B41BE069F87B Q28744621-0C4373A6-680E-4223-A51B-2D43E55390A3 Q30499935-3D4002E6-5C09-4FE3-951F-1090DACF509E Q30500051-88D362DE-1923-4B56-93AA-72BEFE7442A6 Q30536424-7530F111-D65E-4251-B154-B1CF69C11E9C Q30539299-754EC0AC-E0F9-490A-AC0D-B4BF9CE667AD Q30645831-F0A8E376-AF2C-4D91-AAB7-EFE6AD44E2F6 Q30670039-6F34C5B6-7BE4-468D-88BA-5929EFFD3E22 Q30742035-B582A2ED-0021-4404-A5E6-F1FFC575C4A1 Q30833946-D4766E06-E7A8-403D-B58F-693DC286659C Q31132692-2861D192-FC79-48E9-A4C3-CB78F9F8F03A Q33565864-83ED2297-551B-4A16-B564-CBC13AD8C031 Q33577838-135B8E00-E1F6-4D83-8234-3C72D73E0E1F Q33685931-C42B1746-7CFA-44B3-A9F7-B888B0B7B005 Q33785608-D5420984-6379-4F1A-93C5-3C781878823F Q33805831-44E66297-1058-422C-BE61-66067D0550B1 Q33851540-D2273D29-D60F-4344-9A17-4E2B818E537D Q34003440-BF67EECD-73FB-4A51-BA73-11851BE6C98F Q34031225-EA9261E8-C8C3-437A-8B02-CEB598CA1ACA Q34221808-04922FF5-792A-4193-A1B5-139A73292FB2 Q34276961-F8CCA550-6496-40A1-8175-8CAF5E49035C Q34296059-3E5E5FE7-4D57-42A4-8EC0-BCA4457E2FCB Q34322495-B4CE4160-A3E1-43C2-9401-8416F1BCF48C Q34364597-DCEA7B65-5707-4C25-B148-9D3329F9B441 Q34538974-FA93C026-7339-4A0D-B23A-596C8C6CD9C8

P2860

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

http://www.wikidata.org/entity/Q30497419

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@ast

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@en

type

label

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@ast

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@en

prefLabel

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@ast

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@en

P1433

Q30497419-708871DF-4B3F-4FA5-B1E0-CA3748ACE5D1

P1476

Q30497419-8C24246B-C328-4E69-BEFE-7031B22BD34E

P2093

Q30497419-062DE192-147F-4C13-A470-D56CC662CD4C

Q30497419-1FE5C4CE-7152-44C1-BCDE-9ABEA4EF4D2B

Q30497419-2BE2AFC3-2ACE-4089-A9C7-3E3A7F0B0F50

Q30497419-4BFF877C-2A5D-4928-A548-59DF69DC96BF

Q30497419-5D013511-450C-47F4-92E6-5A0B29D6EFDA

Q30497419-79C5D1EA-8D2A-40E5-8DBD-C560C10F0FE0

Q30497419-87CB9ADE-23B6-4E9B-A494-83CB39387D6C

Q30497419-8A7C2135-96C9-42B9-A00F-CF17F6507676

Q30497419-977D5436-C122-48EB-9AB7-EF24F00F0E6D

Q30497419-A4E3B46D-7450-4A3A-8522-1DA3A8B125EA

P2860

Q30497419-07225AAF-71DE-41E5-A4AF-496F1A3D9211

Q30497419-0DC9879A-8280-4851-9DC0-2B23F4976EED

Q30497419-0F146C46-6E0D-4047-AAF8-1CB2F7075A02

Q30497419-14A42E25-26EA-4C9A-A62A-18413BD2AD39

Q30497419-16ED4655-54EB-425C-9753-02C08C485774

Q30497419-171FCBA0-40DE-485A-98AB-9EF7BDA2D3BE

Q30497419-214BB288-7C80-4777-BB83-6AFED999D234

Q30497419-2C9ABA34-99DE-4238-B65D-CFF85286E1D9

Q30497419-2CD6DA4D-5A8F-466D-B399-42EDB4B17416

Q30497419-30F5B782-FD9B-42E5-AE5C-3496045D672E

P304

Q30497419-886D4869-2C56-4B44-B494-9E8E5931A24E

P31

Q30497419-8D29AE91-09A2-4918-B014-58A9D7AD3CF8

P356

Q30497419-D33052B8-3BF3-4966-AE52-6E806C32C356

P407

Q30497419-8B08AF92-F0C9-42D1-BA7A-23FDF91C171C

P433

Q30497419-FD382DCA-2AF9-4A5B-9100-23DE62FC71B0

P478

Q30497419-4A21A687-1312-4254-9DB4-FAFBC47B26C4

P50

Q30497419-4D9A49B7-C23A-4634-A313-03E6FE650C0D

Q30497419-9C25304B-4662-457D-8800-B7A71B911AA3

Q30497419-C2DBFDA8-50CC-41C8-99B3-48F8012E0969

Q30497419-D9BC86A7-8AF0-41A5-9ECA-B5E4FDE06D5B

P577

Q30497419-FDA0DE97-DAC8-41A8-B830-CDD74A3B141C

P698

Q30497419-5C386D4A-538A-4C8B-BF1A-89AD8436C8C8

P921

Q30497419-EF5D2666-3A58-461A-96C1-46C3E328CA76

P932

Q30497419-DF6D9C97-6C80-4519-8DAB-54EBB8D9EAF7

P356

JCO.2009.26.4325

P1433

Journal of Clinical Oncology

P1476

Prognostic and predictive gene ...... ed non-small-cell lung cancer.

@en

P2093

Barbara A Weir

http://www.w3.org/2001/XMLSchema#string

Chang-Qi Zhu

http://www.w3.org/2001/XMLSchema#string

Christine Ladd-Acosta

http://www.w3.org/2001/XMLSchema#string

Dan Strumpf

http://www.w3.org/2001/XMLSchema#string

Frances A Shepherd

http://www.w3.org/2001/XMLSchema#string

Igor Jurisica

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Naoki

http://www.w3.org/2001/XMLSchema#string

Keyue Ding

http://www.w3.org/2001/XMLSchema#string

Lesley Seymour

http://www.w3.org/2001/XMLSchema#string

Melania Pintilie

http://www.w3.org/2001/XMLSchema#string

P2860

Gene ontology: tool for the unification of biology

Mdm2 promotes the rapid degradation of p53

Somatic mutations affect key pathways in lung adenocarcinoma

Characterizing the cancer genome in lung adenocarcinoma.

KEGG for linking genomes to life and the environment

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Regulation of p53 stability by Mdm2

STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells

Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

P304

4417-4424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.26.4325

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Meyerson

Ming-Sound Tsao

Christine Ladd-Acosta

Nathan A Pennell

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20823422

http://www.w3.org/2001/XMLSchema#string

P921

P932

2988634

http://www.w3.org/2001/XMLSchema#string